PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial (Q34138687)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial (English)

1 reference

Europe PubMed Central

31 July 2017

phase III clinical trial

0 references

prevention of HIV/AIDS

0 references

1 reference

based on heuristic

inferred from title

2

object named as

Gita Ramjee

1 reference

Europe PubMed Central

31 July 2017

4

object named as

Helen Rees

0 references

Andrew J Vallely

object named as

Andrew Vallely

12

0 references

Heiner Grosskurth

object named as

Heiner Grosskurth

17

0 references

Richard J. Hayes

object named as

Richard Hayes

20

0 references

object named as

Saidi Kapiga

10

0 references

3

object named as

Anatoli Kamali

1 reference

Europe PubMed Central

31 July 2017

Richard Mutemwa

11

object named as

Richard Mutemwa

1 reference

Europe PubMed Central

31 July 2017

author name string

Sheena McCormack

1

1 reference

Europe PubMed Central

31 July 2017

Helen Rees

4

1 reference

Europe PubMed Central

31 July 2017

Angela M Crook

5

1 reference

Europe PubMed Central

31 July 2017

Mitzy Gafos

6

1 reference

Europe PubMed Central

31 July 2017

Ute Jentsch

7

1 reference

Europe PubMed Central

31 July 2017

Robert Pool

8

1 reference

Europe PubMed Central

31 July 2017

Maureen Chisembele

9

1 reference

Europe PubMed Central

31 July 2017

Thesla Palanee

13

1 reference

Europe PubMed Central

31 July 2017

Yuki Sookrajh

14

1 reference

Europe PubMed Central

31 July 2017

Charles J Lacey

15

1 reference

Europe PubMed Central

31 July 2017

Janet Darbyshire

16

1 reference

Europe PubMed Central

31 July 2017

Albert Profy

18

1 reference

Europe PubMed Central

31 July 2017

Andrew Nunn

19

1 reference

Europe PubMed Central

31 July 2017

Jonathan Weber

21

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

17 September 2010

1 reference

Europe PubMed Central

31 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

31 July 2017

376

1 reference

Europe PubMed Central

31 July 2017

9749

1 reference

Europe PubMed Central

31 July 2017

1329-1337

1 reference

Europe PubMed Central

31 July 2017

A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

A randomised placebo-controlled safety and acceptability trial of PRO 2000 vaginal microbicide gel in sexually active women in Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

The role of partnership dynamics in determining the acceptability of condoms and microbicides.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Recommendations for the clinical development of topical microbicides: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

5 July 2018

International consultation on the criminalization of HIV transmission: 31 October-2 November 2007, Geneva, Switzerland. Joint United Nations Programme on HIV/AIDS (UNAIDS) Geneva, United Nations Development Programme (UNDP), New York, 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

28 October 2018

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

28 October 2018

Direct measurement of in-vivo vaginal microbicide levels of PRO 2000 achieved in a human safety study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

28 October 2018

Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

28 October 2018

Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

28 October 2018

Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956883

28 October 2018

The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961086-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)61086-0

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34138687&oldid=2104815818"